The STC-1 cell line, derived from murine intestinal endocrine tumor ce
lls, has been shown previously to produce a number of peptides includi
ng CCK. These cells express CCK mRNA detectable by Northern analysis a
nd contain approximately 1 ng/mg of immunoreactive CCK as measured by
radioimmunoassay. Surprisingly, given the fact that pro CCK processing
in the gut usually produces immunoreactive forms larger than CCK 8, t
he major CCK immunoreactive product in these cells elutes in the same
fraction as CCK 8 as measured on both Sephadex G-50 chromatography and
HPLC. This cell line, as well as several others which express CCK mRN
A and process pro CCK to CCK 8, also expresses mRNA for the subtilisin
-like endoproteases PC1 and PC2. These enzymes have been implicated in
the processing of other propeptides and are likely candidates for the
dibasic cleavage sites in pro CCK. A significant increase in CCK 8 im
munoreactivity was measured in the media of STC-1 after incubation in
forskolin and IBMX, supporting a cAMP regulated mechanism of release i
n these cells. These cells should be a useful model to study CCK biosy
nthesis, processing and regulation of secretion.